RecruitingNCT03099681
An Observational Study on Epithelioid Sarcoma
Studying Epithelioid sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Italian Sarcoma Group
- Principal Investigator
- Paolo Casali, MDFondazione IRCCS INT Milano
- Intervention
- Treatment for Epitheloid Sarcoma(other)
- Enrollment
- 100 target
- Eligibility
- All sexes
- Timeline
- 2017 – 2030
Study locations (11)
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST, Meldola, FC, Italy
- Istituto Europeo di Oncologia, Milan, MI, Italy
- Istituto Clinico Humanitas, Rozzano, MI, Italy
- Azienda Ospedaliera Universitaria Paolo Giaccone, Palermo, PA, Italy
- Fondazione del Piemonte per l'Oncologia IRCC Candiolo, Candiolo, Torino, Italy
- Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors, Bologna, Italy
- Fondazione IRCCS INT Milano, Milan, Italy
- Irccs Istituto Oncologico Veneto (Iov), Padua, Italy
- Ospedale Misericordia e Dolce Ist. Toscano Tumori, Az. USL4, Prato, Italy
- Campus Biomedico, Roma, Italy
- Istituti Fisioterapici Ospitalieri di Roma, Roma, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03099681 on ClinicalTrials.govOther trials for Epithelioid sarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07089992A Study of Pembrolizumab in People With Ultra-Rare SarcomasMemorial Sloan Kettering Cancer Center
- RECRUITINGPHASE1, PHASE2NCT04390737Evaluate the Safety and Clinical Activity of HH2853Haihe Biopharma Co., Ltd.
- RECRUITINGNCT04300257Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma CareKantonsspital Winterthur KSW